April 3, 2023 02:20 PM EDT
Pharma
FDA+
Manufacturing

FDA re­veals clean­ing and test­ing is­sues at Glob­al Phar­ma In­di­an man­u­fac­tur­ing site

Tyler Patchen

News Reporter

Glob­al Phar­ma Health­care’s man­u­fac­tur­ing site in In­dia has been in­spect­ed by the FDA, re­veal­ing sev­er­al stark qual­i­ty is­sues.

The 14-page re­port …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Ver­tex gets 'van­za triple' ap­proval and Trikaf­ta ex­pan­sion — with boxed warn­ings

FDA ap­proves Lil­ly's Zep­bound for sleep ap­nea, like­ly crack­ing open Medicare mar­ket

Ca­griSe­ma’s weight loss da­ta dis­ap­point­ed. What does No­vo do next?

No­vo Nordisk’s once-dai­ly he­mo­phil­ia drug Al­he­mo ap­proved in US

Bris­tol My­er­s' TYK2 in­hibitor suc­ceeds in pair of Phase 3 pso­ri­at­ic arthri­tis tri­als

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

A service from the Financial Times